In this webinar attendees will learn about FDA’s regulatory expectations for classifying, assessing the risk, testing, and validating a computer system used in FDA-regulated work. Also attendees will learn in detail about the System Development Life Cycle (SDLC) methodology used to approach Computer System Validation (CSV), including all of the phases, sequencing of events, deliverables, and documentation requirements.
The FDA governs the computer systems used to collect, analyze, transfer and report data that is in support of FDA regulated activities required for drug development and approval. FDA oversight is based on a Predicate Rule, known as “Good Practices,” or simply, “GxPs.”
Computer systems subject to GxP requirements must be thoroughly and appropriately validated in accordance with FDA’s guidance on computer system validation. This involves a rigorous set of phases and steps to ensure that, in the language of FDA, “a system does what it purports to do.”
The cost of adequately validating a GxP computer system can be high, and must be weighed against system risk and usage. GAMP 5 system classification guidelines can help ensure that a GxP system is categorized appropriately, based on the type of system and technology involved. Along with risk, system classification can provide a clear-cut pathway for validating a system, based on the appropriate level of testing and validation effort.
All types of data management and information systems will be discussed, including those based on in-house developed code, configurable systems and custom designed systems. Best industry practices and potential pitfalls in validating laboratory systems, along with examples, will be covered in detail.
Ongoing maintenance of the system in a validated state will be discussed, as well as governance, archival and retirement. These functions are critical to maintaining data in a state of integrity. We will also cover the establishment of a Data Governance Committee, the Charter, roles and responsibilities, and oversight. Such a committee is critical to successfully maintaining control over GxP systems and governing the state of integrity of the data housed in them.
We will also discuss the importance of applying good project management, business process re-engineering and organizational change management principles through the validation process and beyond.
Upon completing this course participants should:
This webinar is intended for those working in the FDA-regulated industries, including pharmaceutical, medical device, biotechnology, and tobacco. Functions that are applicable include research and development, clinical sample manufacturing, packaging, labeling, Quality testing, distribution, clinical testing and management, adverse events management and post-marketing surveillance.
You should attend this webinar if you are responsible for planning, executing or managing the implementation of any GxP system governed by FDA regulations, or if you are maintaining or supporting such a system. Examples of who will benefit from this webinar include:
This webinar will also benefit any consultants working in the life sciences industry who are involved in computer system implementation, validation and compliance.
The FDA governs the computer systems used to collect, analyze, transfer and report data that is in support of FDA regulated activities required for drug development and approval. FDA oversight is based on a Predicate Rule, known as “Good Practices,” or simply, “GxPs.”
Computer systems subject to GxP requirements must be thoroughly and appropriately validated in accordance with FDA’s guidance on computer system validation. This involves a rigorous set of phases and steps to ensure that, in the language of FDA, “a system does what it purports to do.”
The cost of adequately validating a GxP computer system can be high, and must be weighed against system risk and usage. GAMP 5 system classification guidelines can help ensure that a GxP system is categorized appropriately, based on the type of system and technology involved. Along with risk, system classification can provide a clear-cut pathway for validating a system, based on the appropriate level of testing and validation effort.
All types of data management and information systems will be discussed, including those based on in-house developed code, configurable systems and custom designed systems. Best industry practices and potential pitfalls in validating laboratory systems, along with examples, will be covered in detail.
Ongoing maintenance of the system in a validated state will be discussed, as well as governance, archival and retirement. These functions are critical to maintaining data in a state of integrity. We will also cover the establishment of a Data Governance Committee, the Charter, roles and responsibilities, and oversight. Such a committee is critical to successfully maintaining control over GxP systems and governing the state of integrity of the data housed in them.
We will also discuss the importance of applying good project management, business process re-engineering and organizational change management principles through the validation process and beyond.
Upon completing this course participants should:
This webinar is intended for those working in the FDA-regulated industries, including pharmaceutical, medical device, biotechnology, and tobacco. Functions that are applicable include research and development, clinical sample manufacturing, packaging, labeling, Quality testing, distribution, clinical testing and management, adverse events management and post-marketing surveillance.
You should attend this webinar if you are responsible for planning, executing or managing the implementation of any GxP system governed by FDA regulations, or if you are maintaining or supporting such a system. Examples of who will benefit from this webinar include:
This webinar will also benefit any consultants working in the life sciences industry who are involved in computer system implementation, validation and compliance.
Carolyn Troiano
Carolyn Troiano has more than 35 years of experience in computer system validation in the tobacco, pharmaceutical, medical device and other FDA-regulated industries. She has worked directly, or on a consulting basis, for many of the larger pharmaceutical and tobacco companies in the US and Europe. She is currently building an FDA computer system validation compliance strategy at a vapor company. Carolyn has participated in industry conferences, and is currently active in the Association of Information Technology Professionals (AITP), and Project Management Institute (PMI) chapters in the Richmond, VA area. Carolyn also volunteers for the PMI’s Educational Fund as a …
Project Management for Non-Project Managers - Scheduling yo…
Imposter Syndrome: How to Define, Understand & Shift Your E…
Contractor vs Employee: How to Tell the Difference and What…
FDA current recommendations related to timely initiation of…
Complying with the NEW I-9 and E-Verify Regulations - The I…
Impact Assessments For Supplier Change Notices
Implicit Bias: Becoming Aware of Your Inner Storyteller
The Federal Anti-Kickback Statute & Stark Law: What Physici…
Building an Effective Injury Management Process
Fatal Errors Employers Make When Updating Employee Handbook…
From Awareness to Action: Going Beyond the Law in Preventin…
Understanding the Changes Coming to NCCI's Experience Mod i…
Onboarding is NOT Orientation - How to Improve the New Empl…
From Awareness to Action: Going Beyond the Law in Preventin…
FDA Compliance and Clinical Trial Computer System Validation
5 Proven Ways To Engage & Retain Your Team Even During The …
Navigating New Paths: Unveiling Your Unique Abilities for a…
Form 1099 Update 2023: Latest Forms, Rules and Reporting Re…
Strategic Interviewing & Selection: Getting the Right Talen…
Excel - Unleashing the Full Potential of New Functions (Exc…
Amazing (!) AI Tools For Building Your Business
Implementing a Robust Change Control Program - Key Elements…
How to Conduct Annual Product Reviews to Achieve GMP Compli…
What Business Leaders Need to Know About Cybersecurity Prep…
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
Understanding Social Security and Optimizing Retirement Inc…
Human Connection Leadership in 3D: Dare. Dream. Deliver.